Michel Meignan

Michel Meignan is a Professor of Nuclear Medicine and former Head of the department of Nuclear Mecicine at Henri Mondor University Hospital, Créteil, France. His main fields of research are interim positron emission tomography (PET) and quantitative PET in lymphoma. He is the Director of the research group “Imaging for evaluation of therapy” (UMR 7054, Créteil, France) and the Scientific Coordinator of the LYSA-IM platform and a member of the scientific board of the Lymphoma Study Association (LYSA). Founder of the International Workshops on PET in Lymphoma (Deauville, France in 2009, and Menton, France in 2010, 2011,2012,2014), he is the author of around 190 scientific publications in international journals (impact factors RG score= 43,7).